04/06/2026
Another powerful moment for Hadassah’s Sharett Institute on the global stage. ✨
At , one of the world’s leading conferences in radiotherapy and radiation oncology, the Sharett Institute Radiotherapy Team played an active role in the international medical conversation, presenting before more than 3,000 physicians, researchers, and experts from around the world.
Dr. Philip Blumenfeld shared interim results from a groundbreaking clinical study on advanced proton therapy in the standing/sitting position for patients requiring re-irradiation of the thoracic region, conducted in collaboration with P-Cure Ltd. at the Proton Therapy Center.
Dr. Marcel Fang, Head of Gynecologic Radiation Oncology, presented on adaptive radiotherapy for postoperative endometrial cancer, reflecting Sharett Institute’s continued commitment to precise, personalized, and innovative cancer care.
Hadassah International is proud to celebrate Dr. Blumenfeld, Dr. Fang, and the entire radiotherapy team as they continue to lead, share knowledge, and bring some of the most advanced medicine to patients.
To read more about the medical work & impact Hadassah International is doing worldwide, subscribe to our monthly newsletter: https://hadassahinternational.org/subscribe-to-the-hadassah-international-monthly-ebulletin/